SLC5A2 and stage 5 chronic kidney disease: Muribaculaceae can be increased using the sodium-glucose cotransporter 2 inhibitors canagliflozin and dapagliflozin to prevent DN progression as well as the onset of end-stage renal disease independent of lowering glucose levels (Wu et al., 2023).